A citation-based method for searching scientific literature

M Borecka, P Zemankova, M Vocka, P Soucek, J Soukupova, P Kleiblova, J Sevcik, Z Kleibl, M Janatova. Cancer Genet 2016
Times Cited: 19







List of co-cited articles
183 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
558
57

PALB2 mutations in European familial pancreatic cancer families.
E P Slater, P Langer, E Niemczyk, K Strauch, J Butler, N Habbe, J P Neoptolemos, W Greenhalf, D K Bartsch. Clin Genet 2010
173
42

Identification of germline genetic mutations in patients with pancreatic cancer.
Erin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, Asad M Ashraf, Maeve A Lowery, Kenneth H Yu, Diane L Reidy, Andrew S Epstein, Anne Lincoln, Amethyst Saldia,[...]. Cancer 2015
128
36

ATM mutations in patients with hereditary pancreatic cancer.
Nicholas J Roberts, Yuchen Jiao, Jun Yu, Levy Kopelovich, Gloria M Petersen, Melissa L Bondy, Steven Gallinger, Ann G Schwartz, Sapna Syngal, Michele L Cote,[...]. Cancer Discov 2012
323
36

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
David B Zhen, Kari G Rabe, Steven Gallinger, Sapna Syngal, Ann G Schwartz, Michael G Goggins, Ralph H Hruban, Michele L Cote, Robert R McWilliams, Nicholas J Roberts,[...]. Genet Med 2015
172
36

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Koji Shindo, Jun Yu, Masaya Suenaga, Shahriar Fesharakizadeh, Christy Cho, Anne Macgregor-Das, Abdulrehman Siddiqui, P Dane Witmer, Koji Tamura, Tae Jun Song,[...]. J Clin Oncol 2017
233
36

Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Chunling Hu, Steven N Hart, William R Bamlet, Raymond M Moore, Kannabiran Nandakumar, Bruce W Eckloff, Yean K Lee, Gloria M Petersen, Robert R McWilliams, Fergus J Couch. Cancer Epidemiol Biomarkers Prev 2016
86
36

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
31

Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Robert C Grant, Iris Selander, Ashton A Connor, Shamini Selvarajah, Ayelet Borgida, Laurent Briollais, Gloria M Petersen, Jordan Lerner-Ellis, Spring Holter, Steven Gallinger. Gastroenterology 2015
197
31

Risk of pancreatic cancer in families with Lynch syndrome.
Fay Kastrinos, Bhramar Mukherjee, Nabihah Tayob, Fei Wang, Jennifer Sparr, Victoria M Raymond, Prathap Bandipalliam, Elena M Stoffel, Stephen B Gruber, Sapna Syngal. JAMA 2009
319
31

BRCA2 germline mutations in familial pancreatic carcinoma.
Stephan A Hahn, Bill Greenhalf, Ian Ellis, Mercedes Sina-Frey, Harald Rieder, Birgit Korte, Berthold Gerdes, Ralf Kress, Andreas Ziegler, John A Raeburn,[...]. J Natl Cancer Inst 2003
342
31

PALB2 mutations in familial breast and pancreatic cancer.
Erin W Hofstatter, Susan M Domchek, Alexander Miron, Judy Garber, Molin Wang, Kathryn Componeschi, Leigh Boghossian, Penelope L Miron, Katherine L Nathanson, Nadine Tung. Fam Cancer 2011
81
31

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
Chunling Hu, Steven N Hart, Eric C Polley, Rohan Gnanaolivu, Hermela Shimelis, Kun Y Lee, Jenna Lilyquist, Jie Na, Raymond Moore, Samuel O Antwi,[...]. JAMA 2018
260
31

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
240
26

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch,[...]. Br J Cancer 2014
257
26

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Kathleen M Murphy, Kieran A Brune, Constance Griffin, Jennifer E Sollenberger, Gloria M Petersen, Ravi Bansal, Ralph H Hruban, Scott E Kern. Cancer Res 2002
322
26

Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Kari G Chaffee, Ann L Oberg, Robert R McWilliams, Neil Majithia, Brian A Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, Richard J Wenstrup, Gloria M Petersen. Genet Med 2018
76
26

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group.
A B Lowenfels, P Maisonneuve, E P DiMagno, Y Elitsur, L K Gates, J Perrault, D C Whitcomb. J Natl Cancer Inst 1997
682
26

The prevalence of BRCA2 mutations in familial pancreatic cancer.
Fergus J Couch, Michele R Johnson, Kari G Rabe, Kieran Brune, Mariza de Andrade, Michael Goggins, Heidi Rothenmund, Steven Gallinger, Alison Klein, Gloria M Petersen,[...]. Cancer Epidemiol Biomarkers Prev 2007
200
26

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
765
26

Germline mutations in Japanese familial pancreatic cancer patients.
Erina Takai, Shinichi Yachida, Kyoko Shimizu, Junji Furuse, Emi Kubo, Akihiro Ohmoto, Masami Suzuki, Ralph H Hruban, Takuji Okusaka, Chigusa Morizane,[...]. Oncotarget 2016
49
26

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
M Goggins, M Schutte, J Lu, C A Moskaluk, C L Weinstein, G M Petersen, C J Yeo, C E Jackson, H T Lynch, R H Hruban,[...]. Cancer Res 1996
496
26

Familial pancreatic cancer.
Gloria M Petersen. Semin Oncol 2016
76
26

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
Maeve A Lowery, Winston Wong, Emmet J Jordan, Jonathan W Lee, Yelena Kemel, Joseph Vijai, Diana Mandelker, Ahmet Zehir, Marinela Capanu, Erin Salo-Mullen,[...]. J Natl Cancer Inst 2018
124
26

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Bella Kaufman, Ronnie Shapira-Frommer, Rita K Schmutzler, M William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M Stemmer, Ayala Hubert,[...]. J Clin Oncol 2015
21

Clinical and genetic characteristics of hereditary pancreatitis in Europe.
Nathan Howes, Markus M Lerch, William Greenhalf, Deborah D Stocken, Ian Ellis, Peter Simon, Kaspar Truninger, Rudi Ammann, Giorgio Cavallini, Richard M Charnley,[...]. Clin Gastroenterol Hepatol 2004
391
21

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
677
21

The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
Marcin R Lener, Aniruddh Kashyap, Wojciech Kluźniak, Cezary Cybulski, Agnieszka Soluch, Sandra Pietrzak, Tomasz Huzarski, Jacek Gronwald, Jan Lubiński. Cancer Res Treat 2017
15
26

Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.
Nicoletta Resta, Daniela Pierannunzio, Gennaro Mariano Lenato, Alessandro Stella, Riccardo Capocaccia, Rosanna Bagnulo, Patrizia Lastella, Francesco Claudio Susca, Cristina Bozzao, Daria Carmela Loconte,[...]. Dig Liver Dis 2013
72
21


Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
Alison P Klein, Kieran A Brune, Gloria M Petersen, Michael Goggins, Anne C Tersmette, G Johan A Offerhaus, Constance Griffin, John L Cameron, Charles J Yeo, Scott Kern,[...]. Cancer Res 2004
438
21

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
21

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Paola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, Linda Battistuzzi, Fiorenza Belli, Loris Bernard, Luigina Bonelli, Giacomo Borgonovo, William Bruno, Franco De Cian,[...]. J Med Genet 2012
53
21

Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell, Marina Pajic, Ann-Marie Patch, David K Chang, Karin S Kassahn, Peter Bailey, Amber L Johns, David Miller, Katia Nones, Kelly Quek,[...]. Nature 2015
21

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
334
21

Fanconi anemia gene mutations in young-onset pancreatic cancer.
Michiel S van der Heijden, Charles J Yeo, Ralph H Hruban, Scott E Kern. Cancer Res 2003
180
21

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
Nicholas J Roberts, Alexis L Norris, Gloria M Petersen, Melissa L Bondy, Randall Brand, Steven Gallinger, Robert C Kurtz, Sara H Olson, Anil K Rustgi, Ann G Schwartz,[...]. Cancer Discov 2016
204
21

Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
Ana Blanco, Miguel de la Hoya, Ana Osorio, Orland Diez, María Dolores Miramar, Mar Infante, Cristina Martinez-Bouzas, Asunción Torres, Adriana Lasa, Gemma Llort,[...]. PLoS One 2013
36
21

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Michael Goggins, Kasper Alexander Overbeek, Randall Brand, Sapna Syngal, Marco Del Chiaro, Detlef K Bartsch, Claudio Bassi, Alfredo Carrato, James Farrell, Elliot K Fishman,[...]. Gut 2020
200
21

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
952
21

A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
Julie Earl, Cristina Galindo-Pumariño, Jessica Encinas, Emma Barreto, Maria E Castillo, Vanessa Pachón, Reyes Ferreiro, Mercedes Rodríguez-Garrote, Silvia González-Martínez, Teresa Ramon Y Cajal,[...]. EBioMedicine 2020
18
22

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
15

Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis.
A B Lowenfels, P Maisonneuve, D C Whitcomb, M M Lerch, E P DiMagno. JAMA 2001
210
15

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
A M Goldstein, M C Fraser, J P Struewing, C J Hussussian, K Ranade, D P Zametkin, L S Fontaine, S M Organic, N C Dracopoli, W H Clark. N Engl J Med 1995
496
15

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Marcia Irene Canto, Femme Harinck, Ralph H Hruban, George Johan Offerhaus, Jan-Werner Poley, Ihab Kamel, Yung Nio, Richard S Schulick, Claudio Bassi, Irma Kluijt,[...]. Gut 2013
485
15

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
287
15

Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
Eric J Jacobs, Stephen J Chanock, Charles S Fuchs, Andrea Lacroix, Robert R McWilliams, Emily Steplowski, Rachael Z Stolzenberg-Solomon, Alan A Arslan, H Bas Bueno-de-Mesquita, Myron Gross,[...]. Int J Cancer 2010
84
15

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
15

Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).
Johanne Geary, Peter Sasieni, Richard Houlston, Louise Izatt, Ros Eeles, Stewart J Payne, Samantha Fisher, Shirley V Hodgson. Fam Cancer 2008
102
15

Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.
Thomas P Potjer, Heidi E Kranenburg, Wilma Bergman, Wouter H de Vos tot Nederveen Cappel, Hester S van Monsjou, Daniela Q C M Barge-Schaapveld, Hans F A Vasen. Eur J Hum Genet 2015
23
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.